Page 3 - Douglasa Treco News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Inozyme Pharma to Present at the H C Wainwright 25th Annual Global Investment Conference

05.09.2023 - BOSTON, Sept. 05, 2023 (GLOBE NEWSWIRE) - Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferation, today .

United statesDouglasa trecoInozyme pharma incAnnual global investment conferenceInvestor relationsInozyme pharma chartNozyme pharma kursNozyme pharma aktie

Inozyme Pharma Reports Second Quarter 2023 Financial Results and Provides Business Highlights

– Interim data readouts from ongoing Phase 1/2 trials of INZ-701 in adults with ENPP1 Deficiency and ABCC6 Deficiency expected in September 2023 – – Plasma pyrophosphate to.

United statesYves sabbaghInozyme pharmaMatt peraKurt gunterStefan rileyDouglasa trecoEuropean medicines agencyEuropean congressExchange commissionCorporate communicationsEuropean calcified tissue society congressDevelopment rd expensesGlobenewswire incPaediatric committeeDrug administration

Form 8-K Inozyme Pharma, Inc For: Jul 26

Form 8-K Inozyme Pharma, Inc For: Jul 26
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDouglasa trecoDrug administrationExchange commissionEuropean unionEuropean medicines agencyDeficiency programSecurities exchangeInozyme pharma incGlobal development strategyCompany open market sale agreementPaediatric committeeSecurities exchange actIts charterPrincipal executive officesZip code

Inozyme Pharma (INZY) Issues Updates on Global Development Strategy of INZ-701

Inozyme Pharma (INZY) Issues Updates on Global Development Strategy of INZ-701
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDouglasa trecoInozyme pharmastefan rileyInozyme pharmaSmithsolve matt peraPaediatric committeeCorporate communicationsInozyme pharma incDeficiency programDrug administrationEuropean medicines agencyExchange commissionPlanned pivotal trialPediatric patientsPrimary endpointsRadiographic global impression

Inozyme Pharma Announces Updates on Global Development Strategy of INZ-701 for the Treatment of ENPP1 Deficiency

Inozyme Pharma Announces Updates on Global Development Strategy of INZ-701 for the Treatment of ENPP1 Deficiency
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDouglasa trecoInozyme pharmastefan rileyInozyme pharmaMatt peraExchange commissionEuropean medicines agencyDeficiency programInozyme pharma incDrug administrationPaediatric committeeCorporate communicationsPlanned pivotal trialPediatric patientsPrimary endpointsRadiographic global impression